HaemoneticsvsEli Lilly and Company

HAE and LLY stock compared: price, dividend, valuation and results, from SEC filings.

HAE

Haemonetics Corporation

$120.68

Value $5.5B

-0.54%
HAE's page

LLY

Eli Lilly and Company

$1,415.32

Value $1.34T

-1.06%
LLY's page

Haemonetics (HAE) has a market value of $5.5B and Eli Lilly and Company (LLY) $1.34T. Over the last year, with dividends, HAE moved +64.2% and LLY +38.9%. The P/E is 52.8 for HAE and 48.4 for LLY. Dividend yield: HAE none, LLY 0.45%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    HAE$5.5B

    LLY$1.34T

    LLY is 243 times HAE

  • Revenue, 12 months

    HAE$1.4B

    LLY$86.5B

    LLY is 63 times HAE

  • Net income, 12 months

    HAE$104M

    LLY$27.6B

    LLY is 265 times HAE

  • Operating margin

    HAE12.8%

    LLY–

  • ROIC

    HAE6.3%

    LLY35.5%

    29.2 points apart

  • P/E

    HAE52.8

    LLY48.4

    HAE is 1.1 times LLY

  • Dividend yield

    HAE0.0%

    LLY0.4%

    0.5 points apart

  • 5-year return

    HAE+103.1%

    LLY+473.3%

    370.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

HAE+103.1%

LLY+473.3%

20040060020222023202420252026
Returns by period
PeriodHAEWith dividendsLLYWith dividends
1 year since November 14, 2025+64.2%Price +64.2%+38.9%Price +38.0%
3 years since November 17, 2023+45.0%+13.2% a yearPrice +45.0%+144.0%+34.6% a yearPrice +139.2%
5 years since November 16, 2021+103.1%+15.2% a yearPrice +103.1%+473.3%+41.8% a yearPrice +449.1%
10 years since November 17, 2016+207.2%+11.9% a yearPrice +207.2%+2,018.4%+35.7% a yearPrice +1,721.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

HAEHaemoneticsLLYEli Lilly and Company

Valuation

HAELLY
Valuation
Price$120.68$1,415.32
Market value$5.5B$1.34T
Enterprise value (EV)$6.3B$1.38T
P/E52.848.4
P/E, 5-year median36.949.9
P/B6.133.2
EV/EBIT35.939.7
Free cash flow yield5.4%1.5%

Results and growth

HAELLY
Results and growth
Revenue, 12 months$1.4B$86.5B
Net income, 12 months$104M$27.6B
Free cash flow, 12 months$298M$19.7B
Earnings per share, 12 months$2.26$30.81
Revenue growth, year on year-2.0%44.7%
Revenue growth a year, past+8.9%over 5 years+21.6%over 5 years
EPS growth a year, past+5.8%over 5 years+27.6%over 5 years

Margins and returns on capital

HAELLY
Margins and returns on capital
Gross margin59.6%83.6%
Operating margin12.8%–
Net margin7.5%31.9%
ROIC6.3%35.5%
ROE12.1%88.6%

Balance sheet

HAELLY
Balance sheet
Cash$261M$4.9B
Total debt$1.1B$49.5B
Net debt / EBITDA3.01.2
Interest cover9.2×38.9×

Dividends and buybacks

HAELLY
Dividends and buybacks
Dividend yield–0.4%
Dividend per share, 12 months–$6.34
Dividend growth a year, past–+15.2%over 5 years
Buyback yield3.2%0.3%
Shareholder yield3.2%0.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: HAE or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, Haemonetics or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.34T) is about 243.4 times Haemonetics ($5.5B), at today's prices.

How did HAE and LLY stock do over the last 10 years?

Since November 17, 2016, HAE's price moved +207.2% and LLY's +1,721.2%. With dividends: HAE +207.2% (+11.9% a year), LLY +2,018.4% (+35.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, HAE or LLY?

The dividend yield at today's price is none for Haemonetics and 0.45% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.

What is the P/E of HAE and LLY?

At today's price, the P/E is 52.8 for HAE and 48.4 for LLY. The median of the last five years was 36.9 and 49.9, which shows where each stands against its own past.

Which has the higher profit margins, Haemonetics or Eli Lilly and Company?

Over the last twelve months, the net margin was 7.5% for Haemonetics and 31.9% for Eli Lilly and Company, and the operating margin 12.8% and –. Revenue was $1.4B and $86.5B.

Which is the better investment, Haemonetics or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.